Characterization of dihydrofolate reductase of Pneumocystis carinii and Toxoplasma gondii.
Pneumocystis carinii and Toxoplasma gondii are opportunistic pathogens of immunosuppressed patients that are susceptible to therapy with inhibitors of dihydrofolate reductase (DHFR). The DHFR of these two organisms was characterized to facilitate the identification of more selective inhibitors. Similar to all reported protozoa, T. gondii has a bifunctional enzyme, of 120,000 Da, that possesses both DHFR and thymidylate synthase (TS) activity. Unexpectedly, P. carinii DHFR activity was present on a small molecule, of 26,000 Da. T. gondii DHFR and TS activity coeluted during affinity chromatography using a methotrexate-Sepharose column, whereas P. carinii DHFR and TS activity could be separated by affinity chromatography using the same column. P. carinii DHFR could be easily distinguished from rat DHFR, which is similar in size, by the differences in Km for dihydrofolate (P. carinii, 17.6 +/- 3.9 microM; rat, 4.0 +/- 2.2 microM). Since all protozoa reported have a large molecular weight, bifunctional DHFR, these studies support the classification of P. carinii as a fungus. These studies also provide a basis for the development of more effective therapeutic agents for these pathogens.
Kovacs
J A
JA
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Allegra
C J
CJ
Masur
H
H
D000818:Animals; D002846:Chromatography, Affinity; D002850:Chromatography, Gel; D007526:Isoelectric Point; D008970:Molecular Weight; D011010:Pneumocystis / Q000201:enzymology*; D013762:Tetrahydrofolate Dehydrogenase / Q000032:analysis*; D013940:Thymidylate Synthase / Q000032:analysis; D014122:Toxoplasma / Q000201:enzymology*
D013762:Tetrahydrofolate Dehydrogenase; D013940:Thymidylate Synthase